Clinical Trials Browser

Phase 3 × Active not recruiting × Leukemia, Myeloid, Chronic-Phase × Clear all

NCT03722420 2024-10-28

Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China)

Phase 3 Active not recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase